Cargando…
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
Adenosine is an immunosuppressive factor that limits anti-tumor immunity through the suppression of multiple immune subsets including T cells via activation of the adenosine A(2A) receptor (A(2A)R). Using both murine and human chimeric antigen receptor (CAR) T cells, here we show that targeting A(2A...
Autores principales: | Giuffrida, Lauren, Sek, Kevin, Henderson, Melissa A., Lai, Junyun, Chen, Amanda X. Y., Meyran, Deborah, Todd, Kirsten L., Petley, Emma V., Mardiana, Sherly, Mølck, Christina, Stewart, Gregory D., Solomon, Benjamin J., Parish, Ian A., Neeson, Paul J., Harrison, Simon J., Kats, Lev M., House, Imran G., Darcy, Phillip K., Beavis, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163771/ https://www.ncbi.nlm.nih.gov/pubmed/34050151 http://dx.doi.org/10.1038/s41467-021-23331-5 |
Ejemplares similares
-
Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
por: Sek, Kevin, et al.
Publicado: (2018) -
Switching on the green light for chimeric antigen receptor T‐cell therapy
por: Mardiana, Sherly, et al.
Publicado: (2019) -
CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
por: Mardiana, Sherly, et al.
Publicado: (2020) -
CAR T cells take centre stage
por: Beavis, Paul A, et al.
Publicado: (2019) -
Generating CAR T cells from tumor-infiltrating lymphocytes
por: Mills, Jane K., et al.
Publicado: (2021)